To test whether the impaired glucose tolerance observed in myeloid Gq is due to changes in insulin secretion, we evaluated β-cell response to different insulin secretagogues under RC and HFD conditions (Figure 2A). The gene discussed is INS; the disease is Impaired glucose tolerance.